MAR 11, 2019 2:54 PM PDT

Fast-Acting Drug For Depression

WRITTEN BY: Nouran Amin

Many individuals going through depression gain little benefit from treatments whether drugs or talk therapy. Depression represents one of the greatest unmet needs in psychiatry. Now, the Food and Drug Administration (FDA) approved a fast-acting prescription antidepressant: a nasal spray version of the widely used anesthetic drug ketamine.

A colored positron emission tomography scan of the brain of a depressed person, highlighting regions (in red) where blood flow and metabolic activity are unusually low. CreditWDCN/Univ. College London, via Science Source.

“Thank goodness we now have something with a different mechanism of action than previous antidepressants,” said Dr. Erick Turner, a former F.D.A. reviewer and an associate professor of psychiatry at Oregon Health & Science University. “But I’m skeptical of the hype, because in this world it’s like Lucy holding the football for Charlie Brown: Each time we get our hopes up, the football gets pulled away.”

The newly approved fast-acting drug, now called esketamine, will bring on a shift from the Prozac era of antidepressant drugs. The spray was developed by Janssen Pharmaceuticals Inc., a branch of Johnson & Johnson, and will be marketed under the name Spravato.

“These are exciting times, for sure,” said Dr. Todd Gould, an associate professor of psychiatry in the University of Maryland School of Medicine. “We have drugs that work rapidly to treat a very severe illness.”

Spravato (esketamine) “works in a different way than traditional antidepressants,” with results in a matter of hours.

Credit: Janssen Pharmaceuticals, Inc.

Esketamine provides renewed hope in treating serious mood problems. Current drug treatments, like Prozac and similar drugs, work to enhance the activity of brain chemical like messengers like serotonin—however, these drugs take weeks or even months for their effects to be felt.

“We’ve had nothing new in 30 years,” said Steven Hollon, a professor of psychiatry and behavior sciences at Vanderbilt University. “So if this drug is an effective way to get a more rapid response in people who are treatment resistant, and we can use it safely, then it could be a godsend.”

Learn more:

Source: NY Times

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 14, 2021
Cancer
Cell Viability- Where to Begin?
APR 14, 2021
Cell Viability- Where to Begin?
Written By: Author As I pondered the title of this article, my thoughts immediately went back to a request by my Ph.D. a ...
JUN 01, 2021
Cannabis Sciences
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
JUN 01, 2021
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
As laws around cannabinoids continue to evolve, some people with chronic illnesses such as multiple sclerosis (MS), are ...
JUN 17, 2021
Drug Discovery & Development
New COVID Drug Reduces Deaths in Patients with no Antibodies
JUN 17, 2021
New COVID Drug Reduces Deaths in Patients with no Antibodies
US drugmaker, Regeneron, in a partnership with Oxford University, has found that its new drug is capable of reducing COV ...
JUL 05, 2021
Drug Discovery & Development
ADHD Drug Reduces Daydreaming, Fatigue and Boredom
JUL 05, 2021
ADHD Drug Reduces Daydreaming, Fatigue and Boredom
Researchers led by New York University have found that a stimulant drug may be able to treat persistent daydreaming, fat ...
JUL 05, 2021
Neuroscience
People with Autism More Likely to Self-Medicate with Recreational Drugs
JUL 05, 2021
People with Autism More Likely to Self-Medicate with Recreational Drugs
Researchers from the University of Cambridge have found that people with autism are more likely than people without the ...
JUL 16, 2021
Cardiology
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
JUL 16, 2021
Therapeutic Exosome Spray May One Day Aid Heart Attack Recovery
When the flow of blood to the heart is blocked, heart cells don't get enough oxygen and begin to die; this is a heart at ...
Loading Comments...